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Hepatitis virusViruses manipulate cellular machinery and functions to subvert intracellular environment conducive for viral
proliferation. They strategically alter functions of the multitasking mitochondria to inﬂuence energy production,
metabolism, survival, and immune signaling. Mitochondria either occur as heterogeneous population of individ-
ual organelles or large interconnected tubular network. Themitochondrial network is highly susceptible to phys-
iological and environmental insults, including viral infections, and is dynamically maintained by mitochondrial
ﬁssion and fusion. Mitochondrial dynamics in tandemwith mitochondria-selective autophagy ‘mitophagy’ coor-
dinates mitochondrial quality control and homeostasis. Mitochondrial dynamics impacts cellular homeostasis,
metabolism, and innate-immune signaling, and thus can bemajor determinant of the outcome of viral infections.
Herein, we review how mitochondrial dynamics is affected during viral infections and how this complex inter-
play beneﬁts the viral infectious process and associated diseases. This article is part of a Special Issue entitled:
Mitophagy.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Viruses are obligate parasites completely reliant on host cell energy
and molecular machinery to multiply. In order to attain a cellular envi-
ronment conducive for proliferation, the viruses strategically modulate
host cells' metabolism and physiology, resulting in a dramatic alteration
of cellular and sub-cellular architecture and functions [1].
Mitochondria have emerged as one of the key organelles in the
maintenance of cellular homeostasis, metabolism, aging, innate immu-
nity, apoptosis and other signaling pathways [2,3]. In the last decade,
work on the mitochondria has expanded our knowledge of its roles in
cellular homeostasis in many parallel ways. At subcellular level, the
size, shape andmotility of themitochondria are governed bymitochon-
drial dynamics that has emerged as a key event which inﬂuences many
cellular processes [4]. Once believed to be a solitary and rigid organelle,
themitochondria constitute a population of organelles that continuous-
ly elongate (by fusion), divide (by ﬁssion) and undergo a controlled
turnover (by mitophagy) [4]. The processes of fusion, ﬁssion and
mitophagy set a fundamental framework of mitochondrial dynamics.
The mitochondrial dynamics (fusion and ﬁssion) in concert with
mitophagy sustains mitochondrial homeostasis and constitutes angy.
ases, Department of Medicine,important arm of mitochondrial quality control. This dynamic process
is sensitive to the changes in the cellular physiological or metabolic
conditions and guards against detrimental stresses that thwart cellular
homeostasis [4].
The mitochondrial dynamics and mitophagy play crucial roles in
metabolism, cellular differentiation, cancer, neurodegeneration and
numerous pathologies [4]. In the past, the aspects of mitochondrial
dynamics were broadly studied in the context of neurodegenerative
disorders like Parkinson's, Alzheimer's and Huntington's diseases [5,6].
The role of mitochondrial dynamics in viral infections is scant and
described only for few viruses. Currently, our understanding of mito-
chondrial dynamics and mitophagy during viral infections is still in its
infancy, but certainly represents an emerging avenue of molecular
investigations in virology. The integral roles of the mitochondria as a
hub of innate immune signaling and metabolism implicate its role in
viral pathogenesis. The mitochondria are either directly targeted by
viral proteins or inﬂuenced by the physiological alterations to cellular
environment during viral pathogenesis like deregulated calcium ho-
meostasis, endoplasmic reticulum stress, oxidative stress and hypoxia.
Recent work by Kim et al., revealed intriguing aspects of how hepatitis
B virus (HBV) and hepatitis C virus (HCV) utilize the alterations inmito-
chondrial dynamics for the maintenance of persistent infection [7–9].
Further investigation of the effect of mitochondrial dynamics in viral in-
fections will enhance our understanding of virus–host interactions and
their role in pathogenesis. Such an understanding will be useful in the
therapeutic design of new antiviral strategies. In this review article,
we discuss the events of virus-regulated mitochondrial dynamics and
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mitochondrial functions has been described elsewhere [10,11].
2. Mitochondrial dynamics and mitophagy
Mitochondrial homeostasis is broadlymaintained by the two closely
interlinked and crucial processes, i.e. mitochondrial dynamics and
mitophagy [12]. Molecular andmorphological analysis ofmitochondrial
network provides evidence that a single mitochondrion, in its life cycle,
undergoes ﬁssion and fusion several times and when the cell's machin-
ery senses any impairedmitochondria, they are eliminated by a process
known as mitophagy [13]. A series of key events associated with this
process is described in Fig. 1. Althoughmitophagy is broadly considered
to be a central route for the elimination of dysfunctional mitochondria,
in many biological events mitophagy plays an active role in eliminating
the fully functional mitochondria such as during starvation, fertilization
and erythroid differentiation [14–16]. The ﬁssion, fusion andmitophagy
are interlinked but distinct processes that together facilitate segregation
of impairedmitochondria and subsequent delivery to the lysosomes for
complete elimination [13]. Fission has been implicated in the sorting of
themitochondriawithmutantmtDNA copies [17]. Unlikeﬁssion, the fu-
sion is a route by which the mitochondria quickly exchange and equili-
brate matrix metabolites, intact mtDNA copies, and mitochondrialHealthy 
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Fig. 1.Mitochondrial quality control. The key events associated with mitochondrial dynamics a
physiological conditions, the mitochondria are usually tubular (A). Physiological stress induces
mitochondria is segregated by the ﬁssion process (C). The impaired mitochondria are selective
repairedmitochondria are recruited to the functionalmitochondrial network by fusionwith othe
are shown in the inset.membrane components. Therefore, this process serves to alleviate the
damage by fusing a partially impaired mitochondrion to a fully healthy,
tubular mitochondrial network by simple exchange of matrix proteins.
At ﬁrst, based on the above explanation, it is easy to make out the in-
verse correlation between the mitochondrial fusion and mitophagy,
however in cellular context, both processes are complementary and to-
gether they aid in the maintenance of homeostasis [12].
The mitochondria that are highly depolarized and irreversibly
damaged are destined to forma pre-mitophagic pool and are eliminated
selectively by mitophagy. The mitochondria that undergo fusion are
selectively rescued from this pre-mitophagic pool and incorporated
back into the functional mitochondrial population. The mitochondrial
membrane potential (ΔΨm) plays an important role in the process of
sorting out and segregation of defective mitochondria [18]. Depending
on the extent of damage, the impaired and segregated daughter
mitochondria are either restored, undergo repair and incorporated
back or are completely eliminated by mitophagy, if the ΔΨm is not
repairable [18,19].
The events of fusion and ﬁssion are highly dynamic. In a cellular
cycle, the mitochondria follow a kiss-and-run pattern, which entails a
brief fusion event (for seconds) followed by ﬁssion [20]. In eukaryotic
cells, mitochondrial life cycle can be seen in two distinct periods i.e.
pre-fusion period and post-fusion period [21]. In pre-fusion stage, theMitophagy
on
D
Parkin
recruitmentE
ndmitophagy affecting themitochondrial quality control are depicted here. Under normal
mitochondrial injury and causes mitochondrial impairment (B). The impaired part of the
ly ﬂagged by the PINK1 (D) that facilitates Parkin recruitment and mitophagy (E). All the
rmitochondria (F). The factors that orchestrate theﬁssion, fusion andmitophagy activities
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a complex network [21]. Sometimes, in the solitary stage of the
mitochondria, even asymmetric ﬁssion can induce remarkable alter-
ation in the ΔΨm because of the unequal distribution of the membrane
surface andnucleoid structure between the twodaughtermitochondria.
Thus, it is presumed that the depolarized mitochondria can also result
from the spontaneous depolarization during solitary stage [12]. Wheth-
er it is spontaneous or stress-induced event, such depolarized
mitochondria are destined for either repair or clearance. Studies that
correlate the size of the mitochondria with the rate of mitophagy
show that the elongated mitochondria exhibit reduced rate of
mitophagy and the mitochondria inside the autophagosomes undergo-
ing mitophagy are smaller in size (b1 μM) [22–24]. Mitophagy of the
larger elongated mitochondria appears less likely. Fission facilitates
the sorting of impaired mitochondria from the healthy mitochondrial
pool. If the damage in a sorted mitochondrion is repairable, it may fol-
low the fusion phase but those in which the damage is irreversible are
eliminated by mitophagy [19]. In this manner, the mitochondrial dy-
namics and mitophagic machinery work in concert to prevent circula-
tion of severely damaged mitochondria into the active and healthy
pool (Fig. 1C–E).
3. Mitochondrial fusion and ﬁssion machinery and their regulation
Mitochondrial dynamics i.e. ﬁssion, and fusion, is coordinated by
dynamin-related proteins. Dynamin has the capacity to oligomerize
into spirals and mechanically remodel membranes by utilizing energy
from GTP hydrolysis. They commonly promote membrane scission
however their role in mitochondrial fusion is quite unique. Mitochon-
drial function and quality are determined by the subtle balance between
continuous ﬁssion and fusion. Below, we discuss the central players of
these processes.
3.1. Fusion proteins
The Fuzzy onion (Fzo) was the ﬁrst fusion regulating protein identi-
ﬁed in Drosophila. Fzo regulates mitochondrial fusion and its deletion
results in fragmented mitochondria [25]. In the Fzo mutant ﬂies, the
mitochondria aggregate and fail to fuse leading to the accumulation of
mitochondria in spermatid [26]. The molecules commandeering fusion
pathway in mammals are Mitofusins (Mfn1 and Mfn2) and optic
atrophy 1 protein (OPA1). Knockdown of any of these proteins leads
to embryonic lethality and mitochondrial dysfunction [27]. Mfn1 and
Mfn2 are homologs of Fzo and have related but discrete roles in control-
ling mitochondrial morphology. Mitofusins are the members of the
membrane anchored dynamin family expressed in a wide variety of
mammalian cells and uniformly localize to the outer mitochondrial
membrane (OMM) [28]. Mitochondrial fusion involves fusion of the
outer and inner mitochondrial membranes resulting in the merger of
two individual mitochondria and concomitant mixing of the mitochon-
drial contents [28]. The OMM fusion is coordinated by Mfn1 and Mfn2.
Mutations in either of the Mfns lead to abnormalities in mitochondrial
morphology associated with dramatic reduction in mitochondrial fu-
sion. Depletion of both Mfn1 and 2 in cells results in poor cell growth,
decreased cellular respiration associated with the heterogeneity of mi-
tochondrial membrane potential [29]. Inner mitochondrial membrane
(IMM) fusion is orchestrated by OPA1. OPA1 is a dynamin-related
GTPase expressed in many mammalian cell types and localizes on
IMM [30]. OPA1 is considered a multifunctional protein with pivotal
roles in mitochondrial cristae architecture, mitochondrial bioenergetics
and apoptosis [13,31].
Overall the mitochondrial fusion is a multistep process with Mfns
mediating the outer membrane fusions followed subsequently by
inner membrane fusions by OPA1 [13]. The presence of Mfns on both
the fusing mitochondria is a prerequisite for outer membrane fusion.
The Mfns on adjacent mitochondria oligomerize bringing the opposingmembranes within close proximity and eventually promoting fusion
by membrane merger [27]. Both Mfn1 and Mfn2 physically interact
homotypically and heterotypically resulting in Mfn1 homotypic oligo-
mers, Mfn2 homotypic oligomers and Mfn1–Mfn2 heterotypic oligo-
mers (Fig. 1F). Interestingly, inner membrane fusion by OPA1 does not
require its presence on adjacent fusing membranes [32].
Both Mfns and OPA1 undergo post-translational modiﬁcations
and proteolysis. Due to differential RNA splicing and precursor pro-
tein processing, OPA1 exists as distinct isoforms. The long isoform
has membrane anchor but the short isoform lacks membrane anchor
but does interact with membranes [33]. Usually both long and short
isoforms drive membrane fusion but under conditions of stress, the
long isoform solely promotes mitochondrial fusion. The activity of
OPA1 is regulated by SIRT3-mediated deacetylation [34]. Moreover,
it has recently been shown that decrease in mitochondrial mem-
brane potential triggers the proteolysis of OPA1 by the isoenzymes
of the adenosine triphosphate (ATP)-dependent matrix AAA (ATPase
associated with diverse cellular activities [m-AAA]) protease and
OMA1 [35,36]. OMA1 is constitutively active under normal cellular
conditions. However, various stress stimuli can enhance its catalytic
activity several fold leading to enhanced turnover. In a recent study,
Baker et al., have identiﬁed a stress sensor N-terminal domain of
OMA1 that is responsible for stress-induced activation of OMA1
[37]. This mechanism probably drives selective fusion of normal mi-
tochondria resulting in isolation of defective/dysfunctional mito-
chondria. JNK-mediated phosphorylation of Mfn2 during genotoxic
stress leads to interaction with Huwe1, an E3 ubiquitin ligase,
resulting in proteasomal degradation of Mfn2, mitochondrial frag-
mentation, and apoptotic cell death [38]. Similarly recruitment of
Parkin to damaged mitochondria also results in the ubiquitination
and degradation of Mfns, which prevents the fusion of damaged mi-
tochondria with the healthy mitochondrial pool [39].
3.2. Fission proteins
The central player in mitochondrial ﬁssion is a cytosolic dynamin-
related GTPase, dynamin-related protein 1 (Drp1). Drp1 is localized pri-
marily in the cytosol and in mammalian cells the accessory proteins
Mid49, Mid51, and mitochondrial ﬁssion factor (Mff) mediate its
recruitment to the mitochondria by acting as ligands for Drp1 on the
mitochondria. Once recruited to the mitochondria, Drp1 oligomerizes
as rings on mitochondrial tubules and causes scission of both outer
and inner mitochondrial membranes [40,41]. Our current understand-
ing of the mitochondrial ﬁssion mechanism is incomplete, however
recent studies suggest that ER tubules wrap around and constrict the
mitochondria, marking them for subsequent scission by Drp1 [42].
These sites of ER–mitochondrial contact are enriched with Drp1
suggesting that ER contact with mitochondria directs mitochondrial
division. Interestingly, mitochondrial constriction at ER contact sites
was also apparent in cells depleted of Drp1 and Mff suggesting that
the ER-mediated ﬂagging of mitochondrial division sites occurs prior
to the mitochondrial recruitment of Drp1 [42]. The mechanical force
required for the constriction of mitochondrial tubules by the ER seems
to be generated by actin assembly at the ER–mitochondria contact
sites via interaction with ER-associated formin INF2 [43]. Genetic or
chemical inhibition of Drp1 leads to elongated mitochondria. The ﬁrst
molecule to be identiﬁed as Drp1 receptor was the Fission1 (Fis1) in
yeast. Fis1, is a small C-tail protein anchored on OMM and displays uni-
form distribution [44]. However, the role of mammalian Fis1 in mito-
chondrial ﬁssion is enigmatic and mitochondrial morphology or
mitochondrial recruitment of Drp1 was unaffected in Fis1 knockout
cells, raising the concern about the role of mammalian Fis1
in mitochondrial ﬁssion [45]. Mitochondrial ﬁssion factor Mff is also a
C-tail anchored protein on OMM and a well-recognized receptor of
Drp1. It transiently interacts with Drp1 through its N-terminal cytoplas-
mic region. In contrast to uniform localization of Fis1 on OMM, Mff
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stimulates mitochondrial recruitment of Drp1 and mitochondrial frag-
mentation and silencing of Mff results in mitochondrial elongation
[46,47]. The MiDs can mediate mitochondrial ﬁssion in the absence of
Fis1 and Mff. Knockdown of either gene results in the increment of mi-
tochondrial length and interconnectivity suggesting that these proteins
positively regulate mitochondrial ﬁssion. Interestingly, overexpression
of MiDs also results in the elongation of the mitochondria. The mito-
chondrial elongation caused by MiD overexpression is associated with
enhanced phosphorylation of Drp1 at S637 site, which negatively
regulates the Drp1 function [40,41]. Although the cells mutated for
Drp1 resist mitochondrial fragmentation induced by depolarization,
they exhibit substantial mitochondrial fragmentation when treated
with apoptotic stimuli such as actinomycin D and etoposide, suggesting
that Drp1-independentmechanisms ofmitochondrialﬁssion also occur.
The mitochondrial fragmentation induced by the pore-forming toxin
listeriolysin O, secreted by the bacterium Listeria monocytogenes, is in-
dependent of traditionalﬁssion proteinDrp1 but dependent on actin cy-
toskeleton [48].
Several posttranslational modiﬁcations of Drp1 regulate mitochon-
drial ﬁssion dictated by various physiological cues. In normal cells,
Drp1 is mostly cytoplasmic with about ~3% of total Drp1 associated
with the mitochondria. Overexpression of Drp1 does not usually lead
to enhanced ﬁssion but stimulation of Drp1 mitochondrial recruitment,
GTPase activity, and spiral assembly directly inﬂuences mitochondrial
ﬁssion (Fig. 1A) [49]. During mitosis Cdk1/cyclin B phosphorylates
Drp1 at S616 residue (amino acid numbering corresponds to human
Drp1), resulting in the upregulation of mitochondrial recruitment of
Drp1 and ﬁssion activity. This regulation is essential in cells undergoing
mitosis to ensure equal distribution of the mitochondria to daughter
cells [50]. During mitosis, Aurora A kinase also promotes mitochondrial
ﬁssion by phosphorylating small Ras-like GTPase, RalA leading to its re-
location to mitochondria, followed by the recruitment of its effector
RalBP1 to the mitochondria. RalBP1 then facilitates CDK1-mediated
Drp1 S616 phosphorylation and recruitment to the mitochondria [51].
Interestingly, a study indicates that high-glucose stimulation of liver-
derived cells induces Ca2+-mediated MAP kinase signaling leading
to ERK1/2-dependent Drp1 S616 phosphorylation and enhanced
mitochondrial ﬁssion [52]. Phosphorylation of Drp1 at S637 residue
leads to inhibition of ﬁssion activity. Protein kinase A (PKA) or cAMP-
dependent protein kinase phosphorylates Drp1 on S637 located in the
GTPase effector domain (GED) and impairs intramolecular interaction
of GED and GTPase domains [53]. During hypoxia, PKA-mediated phos-
phorylation of Drp1 is affected due to the proteasomal degradation of
mitochondrial A-kinase anchoring protein 121 (Akap1) that anchors
PKA to mitochondria [54,55]. Calcium-dependent phosphatase calcine-
urin dephosphorylates Drp1 at S637 and facilitates mitochondrial
recruitment of Drp1 followed by ﬁssion [56]. The same residue is also
dephosphorylated by the phosphatase, PP2A/Bβ 2 [55]. In contrast,
phosphorylation of same residue in response to rise in intracellular
calcium by Ca2+/calmodulin-dependent protein kinase α (CaMKIα) in
neuronal cells or by ROCK1, results in enhanced ﬁssion [57,58]. Surpris-
ingly, recent reports reveal the importance of upstream kinases, rather
than the site of phosphorylation as an important factor that determines
the activity of Drp1. For example, the S616-Drp1 phosphorylation by
CDK1 or PKCΔ, is reported to enhance ﬁssion by activating Drp1 but if
the same site is phosphorylated by CDK5, it was explained to enhance
the dissociation of Drp1 from its oligomeric to monomeric form and
severely reduce its ﬁssion-prompting activity [59]. Calcineurin mediat-
ed dephosphorylation of S637 as well as phosphorylation of S637 by
CaMKIα also enigmatically leads enhanced ﬁssion suggesting that
different cellular contexts may have different effects of Drp1 phosphor-
ylation on same serine residue. However, further studies are needed to
clarify how phosphorylation at the same site, by different kinases can
modulate Drp1 activity with different consequences. In addition,
ubiquitination, sumoylation, and s-nitrosylation have also been shownto modulate Drp1 activity [60–62]. Parkin and mitochondria ubiquitin
ligase (MITOL) facilitate Drp1 degradation via proteasomal pathways
[63,64]. All the post-translational modiﬁcations of the keymolecules in-
volved in the processes of ﬁssion and fusion are outlined in Table 1.
4. Mitophagy machinery and its regulation
Autophagy is a catabolic process, in which a destined cargo is active-
ly engulfed by phagophore and subsequently followed by fusion of
autophagosome with lysosomes to deliver the cargo to the lysosome
for degradation [65]. Autophagy is a nonselective process, but recent
advancements in this ﬁeld have established the presence of selective
autophagy inwhich speciﬁc cargo or damaged organelles are selectively
eliminated. Here, we discuss the selective autophagy of the mitochon-
dria, termed mitophagy. Mammalian mitophagy can be broadly
classiﬁed in two distinct groups; Parkin-dependent, and indepen-
dent forms of mitophagy. Parkin-dependent mitophagy involves se-
lective tagging of damaged mitochondria by PTEN-induced putative
kinase 1 (PINK1) followed by Parkin recruitment to the impaired
mitochondria and subsequent mitophagy [66]. The serine/threo-
nine kinase, PINK1 contains a mitochondrial targeting sequence
(MTS) and is sequentially imported into the healthy mitochondria
via the translocase of outer mitochondrial membrane (TOM) and
translocase of inner mitochondrial membrane (TIM). At the IMM,
PINK1 is processed by the mitochondrial processing protease
(MPP) to excise the MTS, and further cleaved by the presenilin-
associated rhomboid-like protease (PARL) to generate a 52 kDa pro-
tein, which is then rapidly degraded. However in the impaired
mitochondria, the loss of membrane potential (ΔΨm) rapidly perturbs
the import of PINK1 to the IMM and prevents its degradation by MPP,
PARL and other proteases (Fig. 1D). This leads to the display of PINK1
on the surface of the mitochondria, which thereby marks the damaged
mitochondria for Parkin recruitment [66,67] to initiate the process of
mitophagy. Several studies have explained how PINK1 recruits Parkin
to the mitochondria. PINK1 auto-phosphorylation on depolarized mito-
chondria is required for Parkin recruitment and direct phosphorylation
of Parkin by PINK1 at S65 residue has been shown to stimulate Parkin's
E3 ligase activity [68]. PINK1 also phosphorylates S65 residue of ubiqui-
tin that subsequently unlocks Parkin's autoinhibition at the active cyste-
ine site [69]. Ubiquitin mutant S65A inhibited Parkin translocation to
impaired mitochondria [70]. Based on these premise small molecules
that mimic the S65 phospho-ubiquitin can be used as potential thera-
peutic tool against the Parkinson's disease [71]. Together these studies
propose a feed-forward mechanism for Parkin recruitment to the mito-
chondria involving PINK1 mediated phosphorylation of both Parkin
and poly-UB chains synthesized by Parkin to the inner mitochondrial
membrane [70–72]. Some studies suggest a direct physical interaction
between Parkin and PINK1 [66]. It is likely that other substrates of
PINK1 kinase activity are involved in Parkin recruitment to the mito-
chondria. Although PINK1 facilitates Parkin recruitment to the mito-
chondria, in ﬂies it is not the only means for Parkin recruitment.
Mitochondrial morphology in PINK-1 deﬁcient ﬂies can be rescued by
Parkin overexpression and Parkin deﬁcient ﬂies hadmore severe pheno-
type than the later, suggestive of PINK1 independent functions of Parkin
in ﬂies [73]. Can Parkin be recruited to the mitochondria independent of
PINK1 in mammalian cells remains to be determined. However, in one
study, PINK1mediated phosphorylation of Mfn2 was shown to promote
Parkin recruitment on depolarized mitochondria [74].
Parkin ubiquitinates and facilitates degradation OMM proteins such
asMfn1,Mfn2 and TOM complexwhich seems to be essential for subse-
quent autophagic removal of the damaged mitochondria [39]. In agree-
mentwith this notion, inhibition of proteasomal activity impairs Parkin-
dependent mitophagy. The accumulation of proteasomal subunits on
OMM following mitochondrial recruitment of Parkin, suggests that the
proteasomal machinery is directly recruited to the mitochondria to fa-
cilitate degradation. The AAA+ATPase p97, which structurally remodels
Table 1
Post-translationalmodiﬁcations of the protein involved inmitochondrial dynamics. List of important post-translationalmodiﬁcations of the keymolecules ofmitochondrial dynamics and
their upstream modulators with its ﬁnal consequences on cell physiology.
Protein Modiﬁcation Induced by Effect Ref
Drp-1 Phosphorylation (S616) CDK1 Enhanced mitochondrial ﬁssion [50]
Erk1/2 Enhanced mitochondrial ﬁssion [52]
PKCδ Enhanced mitochondrial ﬁssion [142]
CDK5 Reduced mitochondrial ﬁssion [59]
Phosphorylation S637 PKA, Reduced mitochondrial ﬁssion [53]
CaMK1α Enhanced mitochondrial ﬁssion [57]
ROCK1 Enhanced mitochondrial ﬁssion [58]
Dephosphorylation S637 Calcineurin Enhanced mitochondrial ﬁssion [56]
S-Nitrosylation C644 Nitric oxide Enhanced mitochondrial ﬁssion [60]
Sumoylation MAPL Enhanced mitochondrial ﬁssion [61]
Desumoylation SENP5 Reduced mitochondrial ﬁssion [62]
Ubiquitination MITOL Degradation [64]
Parkin Degradation [79]
Fis-1 Ubiquitination MITOL Degradation [64]
Mfn-1 Ubiquitination Parkin Degradation [39]
Ubiquitination MARCH5 Degradation [143]
Mfn-2 Ubiquitination Parkin Degradation [39]
Phosphorylation T111, S442 PINK1 Parkin recruitment [74]
Opa-1 Acetylation K926/931 Stress Reduced GTPase activity [34]
De-acetylation K926/931 SIRT3 High GTPase activity [34]
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shown to be recruited to the mitochondria along with Parkin and regu-
late protein degradation at OMM [39]. Currently, it is unclear how pro-
teins are targeted by Parkin and which of these targets are critical for
initiation of mitophagy. Parkin not only promotes K-48 linked
polyubiquitination which leads to proteasomal degradation but can
also induce the formation of various other lysine-linked polyubiquitin
chains conjugated to its target proteins [72]. Considering Parkin-
mediatedK-63 linked ubiquitination, it is likely that p62 adaptor protein
that binds to K-63 linked polyubiquitin conjugated proteins, plays a role
in recruiting mitochondria to autophagosomes [75]. However, mito-
chondrial elimination has been reported even in the absence of p62
clustering at the mitochondria [76]. The histone deacetylase 6
(HDAC6), also involved in binding ubiquitinated proteins, is recruited
to the mitochondria in Parkin-dependent manner. HDAC6 has been
shown to play a role in autophagosome maturation [77]. PINK1 and
Parkin have also been shown to directly interact with Beclin-1 and
PI3K (phosphatidylinositol-4,5-bisphosphate 3-kinase) complex to pro-
mote autophagy. Parkin also facilitates the recruitment of activating
molecule in Beclin-1 regulated autophagy (Ambra-1) to the mitochon-
dria, which could activate Beclin1 and promote the nucleation of isola-
tion membranes (phagophore) around the mitochondria [78].
Mutations in both Parkin and PINK1 are the most prevalent cause of
autosomal recessive genetic disorder Parkinsonism, which is usually
associated with accumulation of impaired mitochondria leading to
neurodegeneration in Parkinson's disease (PD). This lends support to
the view that PINK1/Parkin-mediated mitophagy is important for mito-
chondrial quality control [5]. PINK1/Parkin pathway, not only initiates
the mitophagic removal of damaged mitochondria, but also facilitates
the segregation of the damaged mitochondria by preventing their
fusion with healthy functional mitochondria. This segregation is
achieved in two different ways; making the impaired mitochondria
fusion defective by Parkin-mediated degradation of Mfns and by
restricting cytosolic motility of the damaged mitochondria by targeting
of Miro (Rho-GTPase), a mitochondrial adapter molecule that anchors
kinesin motor complex to the outer surface of the mitochondria.
PINK1 phosphorylates Miro, which is recognized and degraded by the
Parkin.Miro degradation releases the kinesinmotor from themitochon-
dria, which hinders their motility [39,79]. These events clearly illustrate
that mitochondrial dynamics and mitophagy are interlinked and regu-
lated in a coordinated manner.
Several deviations to the PINK1–Parkin pathway support the exis-
tence of PINK1–Parkin-independent pathways of mitophagy. PINK1–Parkin pathway may not represent the only pathway for steady state
turnover of the mitochondria, because Parkin deﬁciency does not lead
to dramatic loss of mitochondrial mass and mice deﬁcient in Parkin
are normal unless exposed to stress [80]. Allen et al., observed that
iron chelation induces mitophagy independent of PINK1 stabilization
and Parkin activation in primary human ﬁbroblasts as well as those iso-
lated fromPDpatientswith Parkinmutations [81]. AMBRA-1 is reported
to induce Parkin-independent mitophagy by directly interacting with
LC3 via its LC3-interacting region (LIR). AMBRA-1 can inducemitophagy
in Parkin-deﬁcient cells as well as potentiate the Parkin-mediated
mitophagy [82]. In response to energy depletion, AMPK stimulates au-
tophagy by phosphorylating and activating ULK1 [83]. Loss of AMPK
or ULK1 in mammalian cells leads to accumulation of the autophagy
adaptor p62 and deﬁcient mitophagy suggesting that ULK1 is required
for mitochondrial and cellular homeostasis during starvation [83]. A
recent study suggests that ULK1 translocates to the mitochondria and
phosphorylates the FUN14 domain-containing protein (FUNDC1),
which directly binds to LC3 via its LIR motif to regulate mitophagy
[84]. Similarly, BCL2/adenovirus E1B 19 kDa protein-interacting protein
3-like (BNIP3L) or Nix facilitates the elimination of the mitochondria
from reticulocytes during erythrocytematuration by directly interacting
with LC3 via its LIR motif [85]. Another study implicates FUNDC1, an
OMM protein as mediator of hypoxia-induced mitophagy [86]. In neu-
rons, cardiolipin externalization to the outer mitochondrial membrane
serves as a signal for elimination of the damaged mitochondria. The
phospholipid cardiolipin, present in the IMM of the mitochondria
when externalized to the OMM, interacts with LC3 to facilitate mito-
chondrial degradation [87,88]. It is still unknown whether the parkin-
dependent and -independent pathways function in parallel during
depolarization-induced mitophagy.5. Role ofmitochondrial dynamics andmitophagy in cell physiology
Over the past decade, it has become evident that mitochondrial
dynamics and mitophagy constitute the two main pathways re-
quired to maintain mitochondrial quality control and cellular ho-
meostasis. Perturbations in these pathways have physiological
consequences and are among the most common reason underlying
the pathogenesis of many neurodegenerative disorders, cancer,
inﬂammation, metabolic syndrome and cardiac dysfunctions. We
discuss, below, the roles of mitochondrial dynamics and mitophagy
in cellular physiology.
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Perturbation in mitochondrial dynamics and mitophagy usually
generates an unhealthy pool of the mitochondria that create an
energy-deprived condition in the cytosol that can eventually lead to ap-
optosis. Mitochondrial fragmentation has been implicated in apoptosis.
Enhanced fragmentation increases the sensitivity of the cells for apopto-
tic stimuli while enhanced fusion has been associated with delay in Bax
activation, cytochrome C release and cell death [89]. Drp1-mediated
ﬁssion has been shown to facilitate cytochromeC release from themito-
chondria [90]. The Drp-1-dependent remodeling of the OMM facilitates
the oligomerization and insertion of Bax into the mitochondria [91].
Conversely, both Bax/Bak facilitate Drp-1 sumoylation and stabilize
Drp1 on the mitochondria thereby promoting ﬁssion [92]. In the
neuronal cell model of nitric oxide-induced oxidative stress, mitochon-
drial ﬁssion preceded apoptosis, and inhibition of ﬁssion conferred pro-
tection [93]. Enhanced mitochondrial fusion has been shown to protect
cells from mitochondria-triggered apoptosis but not the mitochondria-
independent apoptotic stimuli [94]. Contradicting the common notion,
cytochrome C release was also observed in Drp1 defective cells upon
induction of apoptosis, suggesting that mitochondrial ﬁssion and mito-
chondrial outer membrane permeabilization are independent of each
other. Currently, the precise role of mitochondrial ﬁssion in apoptosis
is not clearly deﬁned, however the anti-apoptotic Bcl2 family members
in their pursuit to promote cellular adaptability to various stressful
conditions may modulate mitochondrial dynamics.
Defective mitochondria are a potential source of reactive oxygen
species (ROS), which can also lead to damage of the healthy mitochon-
dria. Hence, perturbation in the rapid clearance of damaged mitochon-
dria will initiate a vicious cycle of ROS generation and mitochondrial
damage, which eventually deteriorates other cellular components and
promotes cell death [95–97]. Defective mitochondrial quality has been
associated with induction of inﬂammatory responses via the activation
of inﬂammasome [98]. Pre-conditioning the cells to upregulate
mitochondrial quality control pathways has been shown to enhance
resistance to stressful stimuli. Interorganelle contacts are essential for
mitochondrial functions and are implicated in mitochondrial dynamics.
One such example is the involvement of the ER–mitochondria encoun-
tered structure (ERMES) in maintenance of mitochondrial morphology
in budding yeast [99]. In mammals, mitochondrial-associated mem-
branes (MAMs) represent the ER–mitochondria contact sites [89].
Mfn2 is enriched in MAMs and it is proposed that Mfn2 on the ER is
required to stabilize interaction between ER and mitochondria by
engaging in homotypic and heterotypic complexes with Mfn1/2 on
the surface of the mitochondria. Alterations in Mfn2 expression affect
ER–mitochondria contact followed by hindrance to lipid exchange and
calcium signaling between ER and mitochondria [100]. In mammals
many other interactions between ER and mitochondrial proteins have
been reported, however it remains to be determined if these interac-
tions are an integral part of a physical complex [101].
5.2. Innate immunity
The role ofmitochondrial dynamics in innate immune signaling is an
upcoming ﬁeld. Pattern recognition receptors (PRRs), the components
of the innate immune system, recognize pathogen associatedmolecular
patterns (PAMPs) and activate a cascade of complex pathways to elim-
inate infection, sometimes involving the apoptosis of infected cells [1].
Many PRRs have been characterized and each of them has a speciﬁc li-
gand. Many viral PAMPs are recognized by the retinoic acid-inducible
gene I (RIG-I) and RIG-I like receptors (RLRs), which then activate the
mitochondria associated antiviral signaling protein (MAVS) via binding
facilitated by the CARD domains of each protein [102]. Recent studies
implicate the role of mitochondrial dynamics and mitophagy in modu-
lation of this intrinsic defense strategy [103]. Mitochondrial fusion and
ﬁssion play a central role in amplifying or dampening the RLR signaling.Mitochondrial fusion serves to increase MAVS interactions with
downstream signaling molecules resulting in enhanced interferon
(IFN) synthesis upon polyI:C stimulation or Sendai virus infection
[103]. In contrast, themitochondrialﬁssion serves to blockMAVSdown-
stream signaling resulting in reduced IFN synthesis [103]. In agreement
with this notion, ﬁbroblasts lacking both Mfn1 and 2 were impaired in
interferon and pro-inﬂammatory cytokine synthesis in response to
viral infection [104]. Absence of fusion leads to the loss ofmitochondrial
membrane potential in these double-knockout cells, which correlated
with reducedMAVS signaling suggesting thatmitochondrialmembrane
potential may be required for MAVS signaling [104]. It is also envisaged
that mitochondrial fusion and the resultant tubular mitochondrial net-
work formation around viral replication sites assist in concentrating
the MAVS signalosome around sites of viral replication [103,105]. A
recent report claims that Mfn1 promotes dramatic redistribution of
MAVS on the mitochondria after RLR activation and that Mfn1 is
required for recruitment of MAVS-enriched mitochondria to the RIG-I
enriched sites of viral replication [106]. The effect ofmitochondrialmor-
phology is also implicated in regulating the signaling of ER-associated
innate immunity molecule STING (stimulator of interferon genes). Tu-
bular elongated mitochondria tend to interact more with the ER and
therefore assist in STING's downstream interaction with MAVS [103,
105]. We observed that inhibition of mitochondrial ﬁssion by silencing
Drp1 during HCV infection enhanced IFN production indicating that
HCV-mediated altered mitochondrial dynamics serves to perturb
the antiviral defense [8]. This may operate in addition to the HCV NS3/
4a-orchestrated proteolytic cleavage of MAVS to cripple host innate
immunity [107].
6. Mitochondrial dynamics during viral infection
Viruses interferewith themitochondrial pathways and distort mito-
chondrial functions to facilitate their proliferation. Viral strategy to
impede mitochondria-associated antiviral signaling mechanism is one
such paradigm of the virus–mitochondria interactions [102]. The func-
tional implication of mitochondrial dynamics in various mitochondrial
and cellular functions suggests that alteration of mitochondria dynam-
ics can serve as an efﬁcient viral strategy to promote interference of
cellular signaling pathways [103,105]. In addition, the sensitivity of
mitochondrial dynamics to subtle physiological perturbations in cellular
environment makes the effect of viral infections on mitochondrial
dynamics a likely inevitable consequence. The viral infection causes
manyphysiological alterations in host cell andmany of those alterations
can directly affect the mitochondrial dynamics and mitophagy. The
overall effects of viral infection on mitochondrial dynamics and its con-
sequences on viral pathogenesis are illustrated in Fig. 2. We discuss,
below, few of the viruses, which have been characterized for their effect
on mitochondrial dynamics and highlighting the signiﬁcance of these
alterations in the viral infectious process. A brief description of few
viruses and their effects on mitochondrial dynamics and mitophagy
are summarized in Table 2.
6.1. Hepatitis viruses
Chronic infection with hepatitis C virus (HCV) and hepatitis B virus
(HBV) has long been associated with prominent mitochondrial injury
of the liver [108]. Although HBV andHCV differ in their genomic organi-
zation and life cycle, they share similar pathologies, and promote chron-
ic hepatitis, which subsequently progresses into liver ﬁbrosis, cirrhosis
and hepatocellular carcinoma [108,109]. Histopathological features
commonly observed inHBV/HCV infection includemitochondrial swell-
ing and loss of mitochondrial cristae and number [108]. HBV and HCV
infection-associated ER-stress triggers leakage of ER-calcium stores
and their subsequent uptake by the adjacent mitochondria promotes
mitochondrial depolarization and dysfunction, associated with mito-
chondrial ROS generation [108]. We have recently investigated the
Bio-
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Fragmented mitochondria
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Fig. 2.Viruses andmitochondrial dynamics.Model ofmitochondrial dynamics during virus infection explaining the upstream causes of virus induced disruption inmitochondrial dynamics
along with their possible downstream consequences.
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and established a direct relationship between viral infections, mito-
chondrial dynamics, mitochondrial homeostasis, and viral persistence.
HCV: HCV is a positive strand RNA virus belonging to the genus
Hepacivirus in the Flaviviridae family. The 9.5 kb RNAgenome is translat-
ed via an IRES element located in the 5′ untranslated region (UTR) pro-
ducing a ~3000 amino acid precursor polyprotein, which is processed
by cellular and virus-encoded proteases to produce 3 structural and 7
non-structural viral proteins with various functions [110]. Most of the
viral proteins remain associated with the ER membrane and promote
ER stress. HCV induces ER stress and promotes autophagy which plays
a crucial role in HCV RNA translation and HCV replication [111,112].Table 2
Alteration of mitochondrial dynamics by viruses and its physiological signiﬁcance. List of viruse
viral pathogenesis.
Virus [Ref] Effect on mitochondrial
dynamics
Viral protein
involved
Affected
Hepatitis C virus [8,9] Enhanced ﬁssion and
mitophagy
Core, E1–E2 Activati
transloc
Pseudorabies virus [136] Fragmented
mitochondria
Glycoprotein B (GB) Altered
Human cytomegalovirus [130] Enhanced ﬁssion vMIA Affects
Epstein–Barr virus [128] Enhanced ﬁssion LMP2A Up regu
Hepatitis B virus [7] Enhanced ﬁssion
and mitophagy
HBx Parkin a
phosph
Inﬂuenza A virus [98] Induction of mitophagy Unknown The NO
phosph
Inﬂuenza A virus [137,138] Induction of
mitochondrial
fragmentation
PB1-F2
Inhibit M
activati
Measles virus and Newcastle
disease virus [139,140,144]
Induction of mitophagy Unknown Reduce
depend
SARS coronavirus [141] Enhanced fusion ORF-9b ReduceHCV infection promotes mitochondrial abnormalities, and it is assumed
that the ER-stress mediated depletion of ER Ca2+ stores and uptake by
mitochondria paves the way for mitochondrial dysfunctions [113,114].
HCV proteins have also been shown to directly associate with the
mitochondria and localize to the OMM and MAM [107]. HCV core and
NS5a proteins have been shown to perturb complex 1 activity and pro-
mote mitochondrial Ca2+ uptake, ROS production, and mitochondrial
permeability transition [115,116]. HCV NS3/4a protease localizes to
MAM and cleaves MAM-associated MAVS to facilitate evasion
from innate immune response [117]. HCV infection leads to elevation
of ROS in the mitochondria that is induced by calcium signaling [113].
Mitochondrial damage during HCV infection is implicated in thes known to disrupt mitochondrial dynamics and the consequences on cell physiology and
protein(s) Consequences on cell physiology
on of Drp-1, and mitochondrial
ation of Parkin
Inhibition of apoptosis and innate immune
response, facilitates persistent infection
functioning of Miro protein Affects intracellular calcium signaling and
mitochondrial motility
mechanism of Bax Inhibition of apoptosis
lation of Drp-1 Cell migration and apoptosis
nd PINK1 up-regulation and Drp-1
orylation
Inhibition of apoptosis and innate immune
response, facilitates persistent infection
D2 and RIPK2 promote ULK1
orylation to induce mitophagy
Inhibits inﬂammasome activation and reduces
disease severity
AVS and NLRP3 inﬂammasome
on
Inhibit the antiviral response via mitochondrial
pathways
s the level of MAVS via p62
ent mitophagy
Cripples innate immune signaling
s the level of Drp1 and MAVS Cripples innate immune signaling
Mitophagy Reporter Assay
The reporter plasmid encodes mRFP-GFP tandem flourochrome fused in frame with
mitochondrial localization signal of human cytochrome c oxidase subunit VIII The
reporter exploits the differential stability of the RFP and GFP flourochrome in the
acidic environment of the lysosomes. When the RFP-GFP tagged mitochondria are
delivered to the lysosomes, GFP gets rapidly degraded but RFP persists for a while,
hence RFP-GFP tagged mitochondria in lysosomes display only red fluorescence.
RFP plus GFP
RFP plus GFP
Uninfected cell
HCV-infected cell
No Mitophagy
GFPRFP
Mitophagy
The mRFP-eGFP tagged mitochondria
when delivered to the lysosomes
display only red fluorescence, due to
higher stability of RFP compared to
GFP in the acidic environment of the
lysosomes.
Lysosomes
GFPRFP
The mRFP-eGFP tagged mitochondria
in the cytosol display both green and red
fluorescence and merger yields only
yellow mitochondria
Box 1.Mitophagy reporter assay.
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conjunctionwith enhanced lipogenesis and lipid uptake during HCV in-
fection ultimately leads to intracellular accumulation of lipid droplets.
Hepatosteatosis is characterized by the accumulation of LDs which
accelerate progression into end stage liver diseases in chronic hepatitis
C [118]. Other effects on mitochondrial functions during HCV infection
include reduced oxidative phosphorylation and ATP generation [119].
HCV infection induces perinuclear clustering of the mitochondria, a no-
table phenotype in cells exposed to oxidative stress [9]. Our studies have
shown that HCV promotes mitochondrial fragmentation by inducing
Drp-1 S616 phosphorylation. Drp1 phosphorylation at S616 promotes
its mitochondrial translocation and subsequent ﬁssion/fragmentation
of the mitochondria. HCV-infected cells also displayed enhanced ex-
pression of Parkin and PINK1 and mitochondrial recruitment of Parkin.
Mitochondrial recruitment of Parkin in HCV-infected cells was associat-
ed with concomitant increase in autophagic removal of the damaged
mitochondria by Parkin-dependent mitophagy which was elegantly
demonstrated using the mitophagy reporter assay (Box-1) [8,9]. Deple-
tion of Drp-1 and Parkin inHCV-infected cells hinderedHCV-inducedmi-
tochondrial ﬁssion and mitophagy respectively, but led to a marked
increase in mitochondrial apoptotic signaling as evidenced by robust cy-
tochrome C release and increase in caspase-3 activity. Our study sug-
gested that HCV-induced mitochondrial ﬁssion followed by complete
mitophagy is required to sustain mitochondrial homeostasis during the
infection and promote viability of infected cells. The upregulation of mi-
tochondrial quality control pathway likely attenuates the impending
cell death due to the mitochondrial injury incurred during infection. In
addition to promoting viability of infected cells, HCV-induced alteration
of mitochondrial dynamics also subverted the mitochondria-associated
antiviral signaling which was evident by a marked increase in interferon
(IFN) production by silencing Drp-1 expression in HCV-infected cell [8].
HCV cripples the innate immune response by NS3/4a protease-
mediated cleavage of MAVS protein suggesting that the effect of alteredmitochondrial dynamics on MAVS signaling, further complements this
effective viral strategy [120]. These studies clearly show that HCV-
mediated alteration of mitochondrial dynamics and mitophagy is a
major determinant of viral persistence and sheds light on the novel as-
pect of viruses exploiting themitochondrial dynamics and quality control
mechanism to favor viral propagation. Inhibition of mitochondrial ﬁssion
affectsHCV secretion that presumably occurs due to altered rate of glycol-
ysis and ATP synthesis. Alternatively, reactive oxygen species emanating
from accumulated dysfunctional mitochondria can damage lipids and
proteins that could play a crucial role in HCV secretion [8].
HBV:UnlikeHCV, the geneticmakeup of hepatitis B virus (HBV) con-
sists of DNA. HBV replicates via an RNA intermediate and ampliﬁes its
genome by reverse transcription, a strategy similar to retroviruses
[121,122]. A successful recombinant vaccine against HBV is available
with signiﬁcant level of protection (about 98%) against infection. HBV
encodes a regulatory protein, termed HBx or HBV X protein. HBx is
localized to themitochondria via its associationwith VDAC, altersmem-
brane potential, and elevates the levels of calcium and ROS, ultimately
causing damage to the mitochondria [108,123,124]. HBx-regulated cal-
cium signaling and ROS are involved in activation of latent transcription
factors such as STAT-3, NF-kB and NFAT [125]. HBV also induces early
autophagic pathways that subsequently help the viral DNA replication
[126].
HBV, like HCV also induced Drp1-dependent mitochondrial ﬁssion,
and Parkin-dependent mitophagy [7]. Disruption of mitochondrial
dynamics was observed in cell expressing full-length HBV genome or
only HBx but HBx-defective (HBV-ΔX) genome had no effect on mito-
chondrial dynamics reinforcing the issue that HBx is sufﬁcient to pro-
mote mitochondrial damage and alter mitochondrial dynamics [7].
HBV-altered mitochondrial dynamics and mitophagy effectively con-
tribute to mitochondrial quality control resulting in mitochondrial
homeostasis. This promotes the maintenance of persistent infection by
inhibition of apoptosis of HBV infected cells. In Parkin-silenced cells
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chrome C release, caspase-3 activation and poly (ADP-ribose) polymer-
ase (PARP) cleavage [7]. These observations collectively implicate
mitochondrial dynamics in the maintenance of persistent phenotype
in HBV infected hepatocytes [7]. Depletion of Parkin also modestly
affectedHBVDNA synthesis, presumably due to the impairedmitochon-
drial functions or enhanced innate immunity [7].
6.2. Epstein–Barr virus (EBV)
EBV is an oncogenic virus belonging to the herpes virus family and is
implicated in various lymphoid and epithelial cancers [127]. A recent
study has shown that the viral latent membrane protein 2A (LMP2A)
causes elevated mitochondrial ﬁssion in gastric and breast cancer cells.
Their observations revealed that LMP2A-triggered Notch pathway
leads to induction in Drp1 expression and manifests in enhanced
mitochondrial ﬁssion [128]. However, it has to be noted that Drp1 over-
expression per se did not lead to enhance ﬁssion, but the mitochondrial
recruitment of Drp1 and trigger of its GTPase activity is essential to
promote ﬁssion. Drp1 has been implicated in the invasive ability and
enhanced epithelial–mesenchymal transition of breast cancer cells.
Concurrently, this study establishes that altered mitochondrial dynam-
ics plays a critical role in the metastatic behavior of EBV-associated
gastric and breast carcinomas.
6.3. Human cytomegalovirus (HCMV)
Cytomegaloviruses are ubiquitous viruses and pose an important
health problem because of the high frequency of congenital infections
[129]. Severe infections are associated with immunosuppression [129].
In an interesting report by McCormick et al., it has been observed that
ﬁbroblast infected with human cytomegalovirus exhibits a peculiar
characteristic of punctate and dispersed mitochondria reminiscent of
mitochondrial ﬁssion at 24 h post infection. The factor responsible for
this alteration is the product of UL37x1 gene, which is an early anti-
apoptotic gene and also referred to as viral mitochondrion localized
inhibitor of apoptosis (vMIA) [130]. vMIA contains two domains. The
ﬁrst domain is located between amino acids 5 and 34 (30 amino
acids), overlaps with the mitochondrial signal sequence that targets
vMIA to the mitochondria [131]. The second domain located between
amino acids 118 and 147 displays anti-apoptotic properties [131]. A
recombinant fusion protein derived from vMIA consisting of these two
domains is fully functional. vMIA is conserved in all human CMV strains
as well as in other primate CMVs that have been examined [132]. The
vMIA-mediated inhibition of apoptosis is dependent on its interaction
with the pro-apoptotic Bax and Bak proteins [133,134]. But the primary
sequence of vMIA has very low similarity with BCL-xl (anti-apoptotic).
The ectopic Bax is able to rescue the vMIA-mediated fragmented pheno-
type, whereas the BH3 mutant Bax did not show any rescuing effect
[135]. This study indicates involvement of the functions of the Bax and
Bak BH3 domains in both promoting apoptosis as well as regulating
mitochondrial morphology in healthy cells.
6.4. Pseudorabies virus (alphaherpesvirus)
Pseudorabies virus (PRV) and herpes simplex virus type 1 (HSV-1)
infection disruptsmitochondrialmotility andmorphology in the superi-
or cervical ganglion (SCG) neurons of rodents [136]. During PRV infec-
tion the fusion events mediated by glycoprotein B (gB) resulted in
electrical coupling of neurons and increased action potential ﬁring
rates that were causes of intracellular Ca2+ increase and altered mito-
chondrial dynamics [136]. This mechanism is governed by the Ca2+
sensitive cellular protein, Miro, which inhibits the recruitment of
kinesin-1 HC to the mitochondria. PRV-mediated disruption in
mitochondrial dynamics is required for efﬁcient growth and spread
of PRV, indicating that altered mitochondrial transport enhancesalphaherpesvirus pathogenesis and infection. This study has opened
the possibility that kinesin-1 HC is hijacked and recruited for themove-
ment of viral particles or protein cargo during PRV assembly and/or
egress [136].
6.5. Inﬂuenza virus
Infections by inﬂuenza viruses account for millions of deaths world-
wide. An interesting study demonstrates that NOD2 and receptor
interacting protein kinase 2 (RIPK2) respond to inﬂuenza A virus
(IAV) infection by promoting ULK1 phosphorylation and inducing
mitophagy [98]. Ripk2−/− cells exhibited defective mitophagy and trig-
gered greater inﬂammasome activation because of the accumulation of
the damaged mitochondria. This suggests that upregulation of mito-
chondrial quality control during IAV infection dampens inﬂammasome
activation and IL-18 production [98]. This induction in mitophagy was
independent of Parkin but was associated with ULK1 phosphorylation
at serine 555. However, it is not clear if RIPK2 directly phosphorylates
ULK1 or whether other intermediates are involved. Overall this study
suggests that NOD2–RIPK2 signaling protects against virally triggered
immunopathology by upregulating ULK1-dependent mitophagy [98].
The inﬂuenza A viral protein PB1-F2 binds to MAVS and affects IFN
synthesis [137]. PB1-F2 also induces mitochondrial fragmentation,
modulates innate immune response and NLRP3 inﬂammasome activa-
tion [138]. PB1-F2 translocates to mitochondrial inner membrane
space via TOM40 channel and leads to the reduction of mitochondrial
membrane potential. The PB1-F2 variant lacking C-terminal domain
does not affect mitochondrial function [138].
6.6. Measles virus and Newcastle disease virus (NDV)
Measles is an acute, highly infectious disease. The Edmonston strain
of Measles virus (MV-Edm) triggers p62-mediated mitophagy in non-
small cell lung cancer (NSCLC) cells [139]. Defect in autophagy
decreases viral titers and cell death induced by MV-Edm in NSCLC
cells. MV-Edm triggered mitophagy results in the reduction of MAVS
protein levels and subsequent dampening of the innate immune
response. Silencing p62 expression inhibited mitophagy and resulted
in the preservation of mitochondrial mass in MV-Edm-infected cells.
Overall this study suggests that MV usurps mitophagy to mitigate the
innate immune response mediated by RIG-I/MAVS signaling [139]. In-
terestingly, a similar study by the same group suggests that MV-Edm
triggered p62-mediated mitophagy that subverts apoptosis of infected
NSCLC cells by preventing cytochrome C release and leads to enhanced
viral replication [140]. Autophagy-sustained persistent viral replication
and eventually promotes necrotic cell death due to ATP exhaustion and
inhibition of autophagy resulted inmarked decline inMV-Edmassociat-
ed oncolytic activity. Though both the studies agree that MV-Edm
induces p62-dependent mitophagy, and that this induction is re-
quired to promote viral replication, both differ on the physiological
outcome of mitophagy. The same group also showed that the
Newcastle disease virus (NDV) uses a similar strategy and exploits
p62-mediated mitophagy to promote viral propagation. Induction
of mitophagy attenuated cytochrome C release and intrinsic apoptotic
signaling in NDV-infected NSCLC cells and inhibition of mitophagy en-
hanced the oncolytic effect of NDV [140]. It is also likely that inhibition
of mitophagy promotes innate immune signaling leading to cell death
or both mitochondrial – apoptosis and – innate immune signaling
contribute to cell death/oncolysis.
6.7. Severe acute respiratory syndrome-coronavirus
Severe acute respiratory syndrome-coronavirus (SARS-CoV) is a
novel coronavirus, which has emerged as a lethal pathogen and threat
to human health. How SARS-CoV escapes the innate immune signaling
is poorly understood. A recent study revealed that SARS-CoV protein,
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motes proteasomal degradation of Drp1 leading to mitochondrial fusion
[141]. Expression of 9b in HEK 293 cells led to ~70% reduction in Drp1
levels and this reductionwas sensitive to proteasome inhibition but unaf-
fected by inhibition of autophagy [141]. Interestingly, in this study, lower-
ing Drp1 expression was associated with impaired MAVS signaling,
although this reduction was not as effective in comparison to exogenous
expression of ORF-9b protein suggesting that other mechanisms may be
operative. The notion that reduced Drp1 expression or enhanced mito-
chondrial fusion hampersMAVS signaling is in sharp contrast to the com-
mon belief that MAVS signaling and IFN production are enhanced and
dampened by mitochondrial fusion and ﬁssion respectively [141]. It is
further shown that ORF-9b also promotes degradation of MAVS and its
interacting partners by targeting poly(rC) binding protein 2 (PCBP2)
and the HECT domain E3 ligase AIP4 to trigger the degradation of
MAVS, TRAF3, and TRAF6 leading to disruption of MAVS signaling and
IFN production. The localization of ORF-9b to the mitochondria led to
the translocation of PCBP2 from the nucleus to the mitochondria, which
subsequently interacts with AIP4 and targets it to themitochondria. It re-
mains to be clariﬁed if TRAF3 and -6, are direct targets of AIP4. Silencing
PCBP2 or AIP4 expression restored MAVS signaling and IFN production
[141]. These results indicate that SARS-CoV ORF-9b manipulates mito-
chondrial dynamics and targets mitochondrial innate immune signaling
to evade host innate immunity. However, more studies will be required
to elucidate the physiological signiﬁcance of enhanced mitochondrial
fusion in the viral infectious processes or disease pathogenesis.
7. Conclusions
Despite the efforts made in the last few decades in research focusing
on the role of themitochondria and viral infections, many issues remain
unresolved. Recently, the mitochondrial dynamics and mitophagy have
gained substantial attention as these events modulate mitochondrial
functions during viral infections. Current ﬁndings indeed have placed
the mitochondrial dynamics and viral infections at the crossroad.
Undoubtedly, there is a close relationship between the mitochondrial
dynamics and viral infections but in-depth characterizations and their
relevance to pathogenesis may help in understanding the pathogenic
processes. It is important to determine how the players of mitochondri-
al dynamics and mitophagy are differentially regulated during viral
infections and elucidate the different ways viruses exploit these alter-
ations to their own beneﬁts. Elucidation of the functional relevance of
mitochondrial dynamics and viral pathogenesis will open new avenues
for therapeutic design of strategies to combat viral infections and asso-
ciated diseases. Greater understanding of the critical mitochondrial
functions like bioenergetics, apoptosis, innate anti-viral signaling and
inter-organelle cross talk needs to be pursued in future investigations
to elucidate the impact of viral infections on mitochondria and mito-
chondrial dynamics.
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